Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Iradimed (IRMD) over the last 13 years, with Q3 2025 value amounting to $12.8 million.

  • Iradimed's Total Current Liabilities rose 5871.14% to $12.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.8 million, marking a year-over-year increase of 5871.14%. This contributed to the annual value of $8.5 million for FY2024, which is 4786.46% down from last year.
  • According to the latest figures from Q3 2025, Iradimed's Total Current Liabilities is $12.8 million, which was up 5871.14% from $8.8 million recorded in Q2 2025.
  • In the past 5 years, Iradimed's Total Current Liabilities registered a high of $16.3 million during Q4 2023, and its lowest value of $4.6 million during Q1 2021.
  • In the last 5 years, Iradimed's Total Current Liabilities had a median value of $7.6 million in 2023 and averaged $7.9 million.
  • As far as peak fluctuations go, Iradimed's Total Current Liabilities skyrocketed by 9087.91% in 2023, and later tumbled by 4786.46% in 2024.
  • Quarter analysis of 5 years shows Iradimed's Total Current Liabilities stood at $6.8 million in 2021, then grew by 25.37% to $8.6 million in 2022, then soared by 90.88% to $16.3 million in 2023, then crashed by 47.86% to $8.5 million in 2024, then soared by 50.33% to $12.8 million in 2025.
  • Its last three reported values are $12.8 million in Q3 2025, $8.8 million for Q2 2025, and $8.5 million during Q1 2025.